References
Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F., Walmsley, S., Low, D. E. Severe invasive group A streptococcal infections in Ontario, Canada: 1987–1991. Clin. Infect. Dis. 16 (1993) 792–800.
Barry, W., Hudgins, L., Donta, S. T., Pesanti, E. L. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267 (1992) 3315–3316.
Nadal, D., Lauener, R. P., Braegger, C. P., Kaufhold, A., Simma, B., Lütticken, R., Seger, R. A. T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J. Pediatr. 122 (1993) 727–729.
Scott, D. F., Best, G. K., Kling, J. M., Thompson, M. R., Adinolfi, L. E., Bonventre, P. F. Passive protection of rabbits infected with toxic shock syndrome-associated strains ofStaphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. Rev. Infect. Dis. 11 (1989) S214–218.
Hiemstra, P. S., Brands-Tajouiti, J., van Furth, R. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay. J. Lab. Clin. Med. 123 (1994) 241–246.
Stegmayr, B., Bjorck, S., Holm, S., Nisell, J., Rydvall, A., Settergren, B. Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand. J. Infect. Dis. 24 (1992) 589–597.
Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., Cerami, A. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 232 (1986) 977–980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiu, C.H., Lin, T.Y., Ou, J.T. et al. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics. Infection 25, 47–48 (1997). https://doi.org/10.1007/BF02113510
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02113510